Research preview · PMID 34999717
Testosterone replacement therapy and cardiovascular disease.
International journal of impotence research · November 2022 · Jeremy M Auerbach, Mohit Khera
15-second view
Contemporary evidence does not support the historical concern that testosterone replacement therapy broadly increases cardiovascular risk in appropriately selected men; benefits and risks depend on indication, formulation, monitoring, and baseline cardiovascular status.
Evidence: ModerateRelevance: High
Full 1-minute and 5-minute analysis, evidence context, and Rouzier commentary are available to subscribers.
Subscribe for full article intelligenceBack to research